Riskpilot← Back to searchSign inGet full accessMYRE FYSIO AS
ASActiveOrg 971002069Storg 30, 8430 MyrePhysiotherapy activities · NACE 8695Est. 19945 employees
Revenue 2024
NOK 4,2M
+7% vs 2023
EBITDA margin
23.6%
+14% vs 2023
Equity ratio
62.9%
Financial strength
Net profit 2024
NOK 936K
+40% vs 2023
| Revenue | NOK 4,2M | +7% |
| EBITDA | NOK 986K | +14% |
| Net profit | NOK 936K | +40% |
| Total assets | NOK 3,2M | +52% |
| Equity | NOK 2M | +89% |
| Employees | 5 | — |
Legal name
MYRE FYSIO AS
Org number
971002069
Legal form
Aksjeselskap
NACE code
8695 · Physiotherapy activities
Founded
1. januar 1994
Share capital
NOK 39 000
Employees
5 (FTE)
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Company purpose
Almen fysioterapi, psykomotorisk fysioterapi og manuell terapi, og samt hva hermed står i forbindelse, herunder delta i annen virksomhet med økonomisk formål og andre produkter/tjenester som naturlig hører sammen med dette.
Address
Storg 30, 8430 Myre
Phone
+4776133570
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 4 538 | 4 663 | 3 439 | 3 917 | 4 172 |
| Staff expenses | −2 502 | −3 039 | −2 356 | −2 367 | −2 488 |
| EBITDA | 812 | 497 | 105 | 865 | 986 |
| Depreciation & amort. | −186 | −46 | −49 | −52 | −63 |
| EBIT | 626 | 451 | 56 | 813 | 923 |
| Net financials | −500 | 577 | 153 | 38 | 236 |
| Profit before tax | 126 | 1 028 | 209 | 851 | 1 158 |
| Tax | 42 | 203 | 56 | 182 | 222 |
| Net profit | 84 | 825 | 153 | 668 | 936 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 4 945 | 3 862 | 1 362 | 2 074 | 3 156 |
| Equity | 3 381 | 227 | 381 | 1 049 | 1 985 |
| Long-term debt | 656 | 0 | 0 | 0 | 0 |
| Short-term debt | 908 | 3 634 | 981 | 1 025 | 1 172 |
| Total debt | 1 564 | 3 634 | 981 | 1 025 | 1 172 |
EBITDA margin
23.6%
This company
15.8%
Market median
+49% vs market
20202024
Equity ratio
62.9%
This company
38.2%
Market median
+65% vs market
20202024
Return on equity
47.2%
This company
18.4%
Market median
+157% vs market
20202024
Net profit margin
22.4%
This company
8.1%
Market median
+177% vs market
20202024
Asset turnover
1.32×
This company
1.12×
Market median
+18% vs market
20202024
Debt / equity
0.59×
This company
0.62×
Market median
+5% vs market
20202024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
KS Chief Executive Officer | Chief Executive Officer | 2023 |
| Former (1) | ||
UA Deputy Member | Deputy Member | 2011 – 2023 |
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
| Chairman | 2023 | |
| Former (1) | ||
| Chairman | 2011 – 2023 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
MYRE FYSIO AS 
MYRE BEDRIFTSBARNEHAGE ASBoard members of MYRE FYSIO AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Unni Alise Sørdahl | Deputy Member | 0 companies |
| Kristin Sørdahl Myklestad | Chief Executive Officer | 0 companies |
| Asle Sørdahl | Chairman | 0 companies |
| Dag Myklestad | Chairman | 0 companies |